CLDN18 and cancer: To examine whether the alterations in claudin-18 levels at the submucosal invasive front contributed to the proliferation and invasion of cancer cells, an siRNA approach was used to knockdown the protein in the MKN74 GC cell line, which is positive for claudin-18.